This trial will test a contingency management program for patients with opioid use disorder starting outpatient addiction medicine services. The goal is to improve patient outcomes and treatment retention.
- Stimulant Use Disorder
- Opioid Use Disorder
4 Primary · 0 Secondary · Reporting Duration: 30 days post-intervention
3 Treatment Groups
Treatment as usual (TAU)
1 of 3
1 of 3
Attendance + abstinence CM
1 of 3
200 Total Participants · 3 Treatment Groups
Primary Treatment: Contingency Management · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any volunteers being welcomed into the research project at this time?
"Affirmative. Clinicaltrials.gov records demonstrate that this trial, which initially went public on June 15th 2022, is actively recruiting participants; 200 individuals will be enrolled at one medical site in total." - Anonymous Online Contributor
What is the current participation rate for this clinical experiment?
"Affirmative, clinicaltrials.gov exhibits that this trial is actively recruiting patients since its inception on June 15th 2022 and the most recent update also indicates that 200 individuals will be recruited from one location." - Anonymous Online Contributor